On one hand, the use of cetuximab, the monoclonal antibody against the epidermal growth factor receptor (EGFR) in an in vitro co-culture of human CCA cells and NK cells, significantly promoted CCA death by potentiating antibody-dependent NK cytotoxic activity [84]. The gene discussed is EGFR; the disease is cholangiocarcinoma.